Seres Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $610k | 436k | 1.40 |
| 2023-09-30 | $1.7M | 701k | 2.38 |
| 2023-06-30 | $3.1M | 657k | 4.79 |
| 2023-03-31 | $1.8M | 321k | 5.67 |
| 2022-12-31 | $1.9M | 334k | 5.60 |
| 2022-06-30 | $2.0M | 572k | 3.43 |
| 2022-03-31 | $5.2M | 729k | 7.12 |
| 2021-12-31 | $10M | 1.2M | 8.33 |
| 2021-09-30 | $4.0M | 572k | 6.96 |
| 2021-03-31 | $19M | 909k | 20.59 |
| 2020-12-31 | $18M | 745k | 24.50 |
| 2020-09-30 | $17M | 582k | 28.30 |
| 2020-06-30 | $1.7M | 366k | 4.76 |
| 2019-12-31 | $565k | 164k | 3.45 |
| 2019-09-30 | $459k | 114k | 4.01 |
| 2019-06-30 | $2.0M | 628k | 3.22 |
| 2019-03-31 | $743k | 108k | 6.87 |
| 2018-12-31 | $313k | 69k | 4.52 |
| 2018-09-30 | $613k | 81k | 7.59 |
| 2018-06-30 | $621k | 72k | 8.60 |
| 2018-03-31 | $297k | 41k | 7.33 |
| 2017-12-31 | $502k | 50k | 10.14 |
| 2017-09-30 | $460k | 29k | 16.03 |
| 2017-06-30 | $263k | 23k | 11.28 |
| 2017-03-31 | $501k | 44k | 11.28 |
| 2016-12-31 | $352k | 36k | 9.90 |
| 2016-09-30 | $244k | 20k | 12.28 |
| 2016-06-30 | $424k | 15k | 29.05 |
| 2016-03-31 | $3.4M | 128k | 26.56 |
| 2015-12-31 | $3.2M | 91k | 35.07 |
| 2015-09-30 | $1.6M | 55k | 29.68 |